When AI-assisted coding is 20% slower and almost half of it introduces Top 10-level threats, it’s time to make sure we're not ...
At the core of every AI coding agent is a technology called a large language model (LLM), which is a type of neural network ...
MedPage Today on MSN
Overcoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast Cancer
In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...
Game Rant on MSN
Brand New Creature Collector on Steam Feels Like Pokemon & Palworld Finally Agreed to Get Along
Creature collecting games are having a major moment right now, but one upcoming title feels especially promising in the wake ...
Everyday Health on MSN
These are the liquid multivitamins dietitians recommend for kids and adults
Liquid multivitamins provide several vitamins and minerals in an easy-to-take liquid form. Here’s how to pick the best ones, ...
HHS Secretary Robert F. Kennedy Jr.s CDC just funneled a $1.6 million dollar grant to researchers to carry out an unethical and scientifically unjustified randomized clinical trial of the birth dose o ...
The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...
Study Finds on MSN
Menopause Hormone Therapy And Brain Health: What Research On 1 Million Women Tells Us
Review of 1 million women finds no clear link between hormone therapy and dementia risk. Evidence certainty is low with ...
Olema Pharmaceuticals (OLMA) earns a "Strong Buy" rating, driven by advancing palazestrant for 1st-line ER+/HER2- metastatic ...
Objective To examine whether a multicomponent commercial fitness app with very small (‘micro’) financial incentives (FI) ...
This study provides important evidence that negative affect is associated with slower cognitive processing in daily life, with findings replicated across three independent samples and supported by ...
Policy initiatives have come fast and furious at the FDA this year. While guidances on rare diseases and vaccines have consumed most of the ink, policy shifts aimed at improving FDA efficiencies and ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する